The Great Opportunity

TENX10 Calls On Faith Leaders To Help Combat Church Drift

Retrieved on: 
Tuesday, October 10, 2023

PASADENA, Calif., Oct. 10, 2023 /PRNewswire/ -- TENX10, a collaborative discipleship initiative, is calling on Christian faith leaders from all denominations and faith traditions to join them in supporting the young and faithful. Their mission – to make faith matter more for a generation that is leaving the faith at the alarming rate of over 1 million young people annually.

Key Points: 
  • PASADENA, Calif., Oct. 10, 2023 /PRNewswire/ -- TENX10, a collaborative discipleship initiative, is calling on Christian faith leaders from all denominations and faith traditions to join them in supporting the young and faithful.
  • Their mission – to make faith matter more for a generation that is leaving the faith at the alarming rate of over 1 million young people annually.
  • TenX10 is a collaborative discipleship movement with a mission to make faith matter more to 10M youth in the next 10 years.
  • Led by a group of faith leaders, TenX10 offers assessments, resources and support for youth leaders and ministries worldwide.

Elpiscience to Present Its Novel Immunotherapies at Biotech Showcase™ during J.P. Morgan Week 2023

Retrieved on: 
Wednesday, January 4, 2023

Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation cancer immunotherapies, today announced that it will present the latest progress of its innovative molecules and powerful antibody generation platforms at the Biotech Showcase™ conference during J.P. Morgan Week 2023 in San Francisco in January.

Key Points: 
  • Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation cancer immunotherapies, today announced that it will present the latest progress of its innovative molecules and powerful antibody generation platforms at the Biotech Showcase™ conference during J.P. Morgan Week 2023 in San Francisco in January.
  • Elpiscience’s Co-Founder and CEO Darren Ji will also be sharing his perspective on the BioPharma Business in the Asia Pacific Region: Huge Markets, Great Opportunities panel at the conference.
  • We look forward to collaborating with pharmaceutical partners to advance our innovative drug candidates to benefit cancer patients worldwide,” said Darren Ji, Co-Founder, and CEO of Elpiscience.
  • For meeting appointments, registered attendees can send a request through Biotech Showcase Partnering Platform , and or by contacting Elpiscience directly at [email protected] .

Kforce Study: How the Great Resignation is Shaping the Future of Work

Retrieved on: 
Thursday, September 23, 2021

This workforce phenomenon was dubbed the "Great Resignation" by a Texas A&M professor in May 2021.

Key Points: 
  • This workforce phenomenon was dubbed the "Great Resignation" by a Texas A&M professor in May 2021.
  • In a recently released eBook , Kforce experts reveal five data-supported opportunities that will arise in this new era.
  • At Kforce, our promise is to deliver great results through strategic partnership and knowledge sharing.
  • Read more about how Kforce is reimagining the Great Resignation as a Great Opportunity for employers and job seekers alike.